Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Neurooncol. 2017 Jan 23;132(1):181–188. doi: 10.1007/s11060-016-2357-9

Table 4. Baseline Clinical Trial Battery (CTB) Test Scores.

Mean (SD) Median Range % Impaired*
CTB COMP (n=12) -1.63 (1.91) -1.12 -4.65, 1.00 75
Learning and Memory
HVLT-R TR (n=12) -1.54 (1.32) -1.51 -4.16, 0.58 50
HVLT-R DR (n=12) (n=11) -1.92 (1.80) -1.94 -4.29, 1.22 64
HVLT-R R (n=12) -0.52 (1.28) -0.57 -2.91, 0.86 25
Processing Speed
TMTA (n=12) -1.72 (5.14) 0.08 -14.75, 2.20 25
Executive Function
TMTB (n=12) -3.41 (-0.74) -0.74 -13.13, 1.00 42
COWA (n=12) -0.70 (1.09) -0.87 -2.28, 1.29 25

CTB COMP: Clinical Trial Battery Composite, HVLT-R : Hopkins Verbal Learning Test- Revised, TMT : Trail Making Test, COWA : Controlled Oral Word Association

*

Impairment was defined as a score ≤ -1.5 for all CTB tests and as a score ≤ -0.70 for the CTB COMP